Showing results (61-70 of 157) with videos related to
Sort By:
Pageof 16
Archives of Internal Medicine|November 1, 1992
Lack of age-related differences in the clinical presentation of digoxin toxicityJ L Wofford, A R Hickey, W H Ettinger, et al.Lancet (London, England)|April 20, 1996
Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years oldM Pahor, J M Guralnik, C D Furberg, et al.Journal of Internal Medicine|November 1, 1994
Quality control in ultrasound studies on atherosclerosisG L Berglund, W A Riley, R W Barnes, et al.Archives of Internal Medicine|June 23, 1997
Reductase inhibitor monotherapy and stroke preventionJ R Crouse, R P Byington, H M Hoen, et al.Journal of the American Geriatrics Society|April 1, 1995
Lessons learned from a prospective meta-analysisS E Margitić, T M Morgan, M A Sager, et al.The Journal of Dermatological Treatment|October 3, 2003
Physicians underutilize topical retinoids in the management of acne vulgaris: analysis of U.S. National Practice DataR Balkrishnan, A B Fleischer, S Paruthi, et al.American Journal of Epidemiology|November 15, 1995
Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. ACAPS Investigators. Asymptomatic Carotid Atherosclerosis Progression StudyM A Espeland, W Applegate, C D Furberg, et al.Diabetes Care|December 5, 1998
Isradipine in prediabetic hypertensive subjectsR P Byington, C D Furberg, T E Craven, et al.The American Journal of Cardiology|September 28, 1995
Reduction in coronary events during treatment with pravastatin. PLAC I and PLAC II Investigators. Pravastatin Limitation of Atherosclerosis in the Coronary ArteriesC D Furberg, B Pitt, R P Byington, et al.Clinical Pharmacology and Therapeutics|November 1, 1985
Biologic determinants of propranolol disposition: results from 1308 patients in the Beta-Blocker Heart Attack TrialT Walle, R P Byington, C D Furberg, et al.Pageof 16